Skip to main content

Prostate Cancer Research Highlights

The American Cancer Society helps men with prostate cancer in every community. And we’re funding research to help find more cures and save even more lives in the future. 

What to Know About Black Men and Prostate Cancer

Studies show that Black men are 2 times more likely to die from prostate cancer than White men are. A main cause could be disparities in the assessibility and delivery of quality care. 

Evidence keeps building that Black men are less likely to receive high-quality care for prostate cancer. When treatment is similar, prostate cancer 10-year survival is comparable or even higher among Black men.

Eating Grains May Lower the Risk of Developing Advanced Prostate Cancer

whole grain stock photo from usda

Screening for Prostate Cancer Before and After COVID-19

Fewer men were getting screened for prostate cancer in 2023, after the COVID-19 pandemic, than they had been before it started in 2019. Read about the study.

38%

PreCOVID, 2019, prostate cancer screening prevalence

34.3%

2nd year of the pandemic, 2021, prostate cancer screening prevalence

36.6%

PostCOVID-19, 2023, prostate cancer screening prevalence

Prostate Cancer Incidence Rates Worldwide

Red countries: Have the highest incidence rates for prostate cancer, including the United States, Brazil, the Scandinavian countries, the British Isles, France, Australia, and New Zealand.

Dark blue countries: Have the lowest incidence of prostate cancer, including Niger, Sudan, and Ethiopia in Africa; Saudi Arabia; much of Central Asia; much of South Asia, including India; and much of East Asia, including Mongolia and China.

See Prostate Cancer Is #1 for 118 Countries Globally

Differences in Prostate Cancer Incidence Rates Worldwide in Men, 2022, map for news story: "Cancer in Men: Prostate Cancer is #1 for 118 Countries Worldwide"

Eye-Opening Prostate Cancer Statistics

70%

how much higher the prostate cancer incidence rate is for Black men compared to White men

100%

5-year survival rate for 83% of men diagnosed with localized prostate cancer

34%

5-year survival rate for men diagnosed with distant-stage prostate cancer

More Prostate Cancer Research Stories

Prostate Cancer News

We Fund Cancer Researchers Across the US

The ACS funds scientists who conduct research about prostate cancer at medical schools, universities, research institutes, and hospitals throughout the United States. We use a rigorous and independent peer review process to select the most innovative research project proposals to fund. 

Stats below are as of February 20, 2025. 

46

prostate cancer grants

$40M

funding for prostate cancer